Ignite Creation Date:
2025-12-24 @ 5:31 PM
Ignite Modification Date:
2026-02-27 @ 6:31 AM
Study NCT ID:
NCT02748668
Status:
TERMINATED
Last Update Posted:
2024-06-05
First Post:
2016-04-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Extracorporeal Membrane Oxygenation (ECMO): Blood Cells
Sponsor:
Corewell Health West
Organization:
Study Overview
Official Title:
Extracorporeal Membrane Oxygenation: Blood Cells
Status:
TERMINATED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Study was not able to achieve primary objective and there is no intention to work towards its achievement
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of the study is to predict outcomes of patients on extracorporeal membrane oxygenation (ECMO) therapy by correlating cytokines and inflammatory cell patterns to clinical outcomes using data collected in the ECMO Registry at Spectrum Health.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: